≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Hypospadias

DOID EFO Endpoint Browser PheWeb

Q17_HYPOSPADIAS

hypospadias: Hypospadias is the displacement of the urethral meatus on the ventrum of the penis. This abnormality is associated with a varyingly bent, twisted penis and opened dorsal prepuce.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

only males

226725

2. Check conditions

None

226725

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q54
  • Cause of death: ICD-10 — Q54

2 out of 7 registries used, show all original rules.

146

4. Check minimum number of events

None

146

5. Include endpoints

None

146

6. Filter based on genotype QC (FinnGen only)

134

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_GENITAL_ORGANS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
Q5
Name in latin
Hypospadia

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 134 - 134
Unadjusted period prevalence (%) 0.06 - 0.06
Median age at first event (years) 10.60 - 10.60

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
146
Matched controls
1460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q54.0
ICD-10 Finland
Hypospadias, balanic
+∞
92.9
79
*
XKD00
NOMESCO Finland
Uroflowmetry
11.1
46.7
69
109
Q54.9
ICD-10 Finland
Hypospadias, unspecified
+∞
45.2
41
*
Q54.1
ICD-10 Finland
Hypospadias, penile
+∞
41.7
38
*
KGH61
NOMESCO Finland
Correction of distal hypospadia
+∞
40.5
37
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
10.0
39.2
58
90
UKC02
NOMESCO Finland
Cystoscopy
8.2
29.2
48
82
Q54.2
ICD-10 Finland
Hypospadias, penoscrotal
+∞
21.4
20
*
Q54.4
ICD-10 Finland
Congenital chordee
+∞
18.1
17
*
J01EA01
ATC
trimethoprim; systemic
7.0
16.4
28
48
TKD00
NOMESCO Finland
Dilatation of urethra
89.3
14.9
16
*
7526B
ICD-9 Finland
Congenital anomalies of genital organs, Hypospadias and epispadias[HYPOSPADIA]
+∞
14.8
14
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.9
14.5
68
268
N35.9
ICD-10 Finland
Urethral stricture, unspecified
59.4
14.1
16
*
KGH62
NOMESCO Finland
Total correction of proximal hypospadia
+∞
11.6
11
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.8
10.7
21
41
KDH70
NOMESCO Finland
Plastic repair of stricture of urethra
+∞
10.5
10
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
5.5
9.6
20
41
KDH10
NOMESCO Finland
Meatoplasty of urethra
+∞
9.5
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
9.0
65
316
N30.0
ICD-10 Finland
Acute cystitis
8.8
8.7
18
23
WX308
NOMESCO Finland
Sacral anesthesy
21.6
8.6
12
6
N35.8
ICD-10 Finland
Other urethral stricture
95.3
8.5
9
*
N99.1
ICD-10 Finland
Postprocedural urethral stricture
+∞
8.4
8
*
75220
ICD-8 Finland
Congenital anomalies of genital organs, Hypospadia glandis
+∞
8.4
8
*
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
+∞
8.4
8
*
7421
FHL
Single-stage total correction, in distal hypospadia
+∞
8.4
8
*
KGH20
NOMESCO Finland
Correction of induration or curvature of penis
+∞
7.3
7
*
KGH69
NOMESCO Finland
Other correction of hypospadia
+∞
7.3
7
*
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
+∞
7.3
7
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
31.7
7.2
9
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
31.7
7.2
9
*
J01MA02
ATC
ciprofloxacin; systemic
2.8
7.2
48
219
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
+∞
6.3
6
*

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Cystoscopy
UKC02 [2001306005]
—
2.2e+00
—
1.0e+50
—
3.2e+00
2.3e+00
—
—
cases:6.59%
controls:0.80%
—
—
cases:14.29%
controls:0.00%
—
—
cases:12.50%
controls:0.59%
cases:10.98%
controls:1.23%
—
6
7
85
871
—
13
0
78
878
—
11
5
77
848
9
10
73
800
Pediatric Surgery
OMOP4822020 [45756819]
1.3e+00
2.5e+00
—
1.0e+50
—
2.7e+00
2.2e+00
cases:6.82%
controls:1.86%
cases:7.69%
controls:0.68%
—
—
cases:7.69%
controls:0.00%
—
—
cases:11.36%
controls:0.82%
cases:19.51%
controls:2.72%
6
16
82
843
7
6
84
872
—
7
0
84
878
—
10
7
78
846
16
22
66
788
Urology
34 [38004474]
1.1e+00
2.0e+00
2.3e+00
1.0e+50
—
3.2e+00
1.3e+00
cases:14.77%
controls:5.36%
cases:16.48%
controls:2.51%
cases:5.49%
controls:0.57%
cases:43.96%
controls:0.00%
—
—
cases:35.23%
controls:2.11%
cases:20.73%
controls:6.91%
13
46
75
813
15
22
76
856
5
5
86
873
40
0
51
878
—
31
18
57
835
17
56
65
754
Uroflowmetry
44856007 [4261340]
8.3e-01
—
—
1.0e+50
—
3.6e+00
2.6e+00
cases:5.68%
controls:2.56%
—
—
—
—
cases:12.09%
controls:0.00%
—
—
cases:18.18%
controls:0.59%
cases:17.07%
controls:1.48%
5
22
83
837
—
—
11
0
80
878
—
16
5
72
848
14
12
68
798
Ultrasound measurement of residual urine
KC1EE [2001305918]
—
—
—
1.0e+50
—
3.1e+00
2.6e+00
—
—
—
—
—
—
cases:5.49%
controls:0.00%
—
—
cases:11.36%
controls:0.59%
cases:12.20%
controls:0.99%
—
—
—
5
0
86
878
—
10
5
78
848
10
8
72
802
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
5.8e-01
1.9e+00
—
—
—
2.7e+00
1.2e+00
cases:5.68%
controls:3.26%
cases:8.79%
controls:1.48%
—
—
—
—
—
—
cases:7.95%
controls:0.59%
cases:13.41%
controls:4.57%
5
28
83
831
8
13
83
865
—
—
—
7
5
81
848
11
37
71
773
Outpatient Visit
OP [9202]
3.4e-01
6.4e-01
4.4e-01
—
1.5e+00
1.2e+00
1.4e+00
cases:60.23%
controls:51.92%
cases:56.04%
controls:40.32%
cases:16.48%
controls:11.28%
—
—
cases:29.67%
controls:8.88%
cases:71.59%
controls:42.09%
cases:89.02%
controls:66.30%
53
446
35
413
51
354
40
524
15
99
76
779
—
27
78
64
800
63
359
25
494
73
537
9
273
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
1.2e+00
2.6e+00
—
—
—
—
1.4e+00
cases:9.09%
controls:2.91%
cases:14.29%
controls:1.25%
—
—
—
—
—
—
—
—
cases:14.63%
controls:3.95%
8
25
80
834
13
11
78
867
—
—
—
—
12
32
70
778
Outpatient Hospital
22 [8756]
7.7e-01
7.7e-01
—
1.0e+50
1.9e+00
1.9e+00
7.5e-01
cases:38.64%
controls:22.58%
cases:14.29%
controls:7.18%
—
—
cases:23.08%
controls:0.00%
cases:8.79%
controls:1.37%
cases:26.14%
controls:5.16%
cases:29.27%
controls:16.30%
34
194
54
665
13
63
78
815
—
21
0
70
878
8
12
83
866
23
44
65
809
24
132
58
678
Inpatient Hospital
21 [8717]
2.1e-01
7.7e-01
1.3e+00
1.0e+50
2.2e+00
1.6e+00
5.1e-01
cases:36.36%
controls:31.66%
cases:20.88%
controls:10.93%
cases:6.59%
controls:1.82%
cases:23.08%
controls:0.00%
cases:13.19%
controls:1.71%
cases:35.23%
controls:9.73%
cases:34.15%
controls:23.70%
32
272
56
587
19
96
72
782
6
16
85
862
21
0
70
878
12
15
79
863
31
83
57
770
28
192
54
618
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 [3013603]
2.0e-01
7.3e-01
2.8e+00
—
—
5.6e-01
9.0e-03
cases:10.23%
controls:8.50%
cases:9.89%
controls:5.01%
cases:8.79%
controls:0.57%
—
—
—
—
cases:7.95%
controls:4.69%
cases:12.20%
controls:12.10%
9
73
79
786
9
44
82
834
8
5
83
873
—
—
7
40
81
813
10
98
72
712
Leukocytes [#/volume] in Urine
30405-5 [3018095]
7.4e-01
1.6e+00
—
—
—
2.7e+00
1.2e+00
cases:5.68%
controls:2.79%
cases:7.69%
controls:1.71%
—
—
—
—
—
—
cases:7.95%
controls:0.59%
cases:12.20%
controls:4.07%
5
24
83
835
7
15
84
863
—
—
—
7
5
81
848
10
33
72
777
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
—
2.0e+00
—
—
—
2.0e+00
2.5e+00
—
—
cases:5.49%
controls:0.80%
—
—
—
—
—
—
cases:5.68%
controls:0.82%
cases:8.54%
controls:0.74%
—
5
7
86
871
—
—
—
5
7
83
846
7
6
75
804
Medical doctor
Z2221 [2001311556]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:6.82%
controls:0.70%
—
—
—
—
—
—
—
6
6
82
847
—
Infectious Disease
44 [38004484]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:0.86%
—
—
—
—
—
—
6
7
76
803
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:0.86%
—
—
—
—
—
—
6
7
76
803
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:9.76%
controls:1.23%
—
—
—
—
—
—
8
10
74
800
trimethoprim; oral, parenteral
J01EA01 [21602931]
1.6e+00
—
—
—
—
—
2.1e+00
cases:5.68%
controls:1.16%
—
—
—
—
—
—
—
—
—
—
cases:8.54%
controls:1.11%
5
10
83
849
—
—
—
—
—
7
9
75
801
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:0.99%
—
—
—
—
—
—
6
8
76
802
Emergency Room Visit
ER [9203]
1.0e-01
8.3e-01
—
—
1.9e+00
9.6e-02
4.4e-01
cases:27.27%
controls:25.26%
cases:19.78%
controls:9.68%
—
—
—
—
cases:8.79%
controls:1.37%
cases:10.23%
controls:9.38%
cases:40.24%
controls:30.25%
24
217
64
642
18
85
73
793
—
—
8
12
83
866
9
80
79
773
33
245
49
565
Treatment plan or consultation
WZC00 [2001310885]
—
—
—
—
—
1.9e+00
6.2e-01
—
—
—
—
—
—
—
—
—
—
cases:7.95%
controls:1.29%
cases:7.32%
controls:4.07%
—
—
—
—
—
7
11
81
842
6
33
76
777
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
8.6e-01
1.2e+00
—
—
—
1.9e+00
9.3e-01
cases:12.50%
controls:5.70%
cases:9.89%
controls:3.19%
—
—
—
—
—
—
cases:7.95%
controls:1.29%
cases:15.85%
controls:6.91%
11
49
77
810
9
28
82
850
—
—
—
7
11
81
842
13
56
69
754
General Surgery
2 [38004447]
2.3e-01
6.6e-01
—
1.0e+50
—
1.7e+00
3.6e-01
cases:21.59%
controls:17.93%
cases:9.89%
controls:5.35%
—
—
cases:25.27%
controls:0.00%
—
—
cases:21.59%
controls:4.69%
cases:21.95%
controls:16.42%
19
154
69
705
9
47
82
831
—
23
0
68
878
—
19
40
69
813
18
133
64
677
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.8e-01
—
-1.0e+50
—
—
—
1.5e+00
cases:5.68%
controls:3.96%
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
cases:13.41%
controls:3.21%
5
34
83
825
—
0
7
91
871
—
—
—
11
26
71
784
One hour or less
ZXE00 [2001311394]
7.4e-01
—
—
—
2.3e+00
1.3e+00
1.5e+00
cases:9.09%
controls:4.54%
—
—
—
—
—
—
cases:5.49%
controls:0.57%
cases:6.82%
controls:1.99%
cases:14.63%
controls:3.70%
8
39
80
820
—
—
—
5
5
86
873
6
17
82
836
12
30
70
780
Normoblasts [#/volume] in Blood
715-3 [3021589]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:15.85%
controls:4.81%
—
—
—
—
—
—
13
39
69
771
Intraoral radiographic dental examination
EB1AA [2001301903]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:18.29%
controls:6.67%
—
—
—
—
—
—
15
54
67
756
Pharmacy visit
OMOP4822462 [581458]
1.1e-01
2.9e-01
6.2e-01
1.4e+00
9.7e-01
4.7e-01
7.9e-01
cases:90.91%
controls:89.99%
cases:76.92%
controls:71.41%
cases:47.25%
controls:32.46%
cases:8.79%
controls:2.28%
cases:53.85%
controls:30.75%
cases:80.68%
controls:72.33%
cases:95.12%
controls:89.88%
80
773
8
86
70
627
21
251
43
285
48
593
8
20
83
858
49
270
42
608
71
617
17
236
78
728
4
82
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
Sprain and strain of ankle
S93.4 [45550848]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
88
851
—
—
—
—
—
—
sulfadiazine and trimethoprim
J01EE02 [21602962]
6.1e-01
1.1e+00
—
—
—
—
—
cases:13.64%
controls:7.92%
cases:7.69%
controls:2.62%
—
—
—
—
—
—
—
—
—
—
12
68
76
791
7
23
84
855
—
—
—
—
—
Foot/toe symptom/complaint
L17 [2002000641]
—
-1.0e+50
—
—
—
—
1.0e+00
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
—
cases:6.10%
controls:2.22%
—
0
9
91
869
—
—
—
—
5
18
77
792
Otolaryngology
4 [38004449]
8.3e-02
—
-1.0e+50
—
-1.0e+50
8.6e-01
3.6e-01
cases:13.64%
controls:12.69%
—
—
cases:0.00%
controls:1.03%
—
—
cases:0.00%
controls:1.14%
cases:7.95%
controls:3.52%
cases:15.85%
controls:11.60%
12
109
76
750
—
0
9
91
869
—
0
10
91
868
7
30
81
823
13
94
69
716
clobetasol
D07AD01 [21602141]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.81%
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
0
7
88
852
0
6
91
872
—
—
—
—
0
8
82
802
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.2e-01
1.2e+00
—
—
—
—
3.6e-01
cases:5.68%
controls:4.19%
cases:8.79%
controls:2.73%
—
—
—
—
—
—
—
—
cases:10.98%
controls:7.90%
5
36
83
823
8
24
83
854
—
—
—
—
9
64
73
746
More than three and less than five hours
ZXE20 [2001311408]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.48%
0
6
88
853
—
—
—
—
—
0
12
82
798
Prostate specific Ag panel - Serum or Plasma
53764-7 [3039443]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Atherosclerotic cardiovascular disease, so described
I25.0 [45552783]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Monocytes/Leukocytes in Blood
26485-3 [3019069]
—
—
-1.0e+50
—
—
—
7.7e-01
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
cases:12.20%
controls:6.05%
—
—
0
5
91
873
—
—
—
10
49
72
761
General medical examination
Z00.0 [45585791]
—
-1.0e+50
—
—
—
-1.0e+50
1.2e+00
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
cases:0.00%
controls:0.70%
cases:6.10%
controls:1.98%
—
0
5
91
873
—
—
—
0
6
88
847
5
16
77
794
Hyperlipidaemia, unspecified
E78.5 [45537986]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
0
11
82
799
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
—
—
—
—
—
-1.0e+50
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.17%
cases:7.32%
controls:2.35%
—
—
—
—
—
0
10
88
843
6
19
76
791
Acute apical periodontitis of pulpal origin
K04.4 [45567286]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
formoterol and budesonide
R03AK07 [21603281]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
0
6
88
853
—
—
—
—
—
0
8
82
802
terbutaline; inhalant
R03AC03 [21603257]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
0
6
88
847
—
s-atenolol; oral
C07AB11 [21601693]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Examination of ears and hearing
Z01.1 [45547279]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
—
betamethasone
A07EA04 [21600656]
1.3e-01
—
—
—
—
—
3.3e-01
cases:5.68%
controls:5.01%
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:4.44%
5
43
83
816
—
—
—
—
—
5
36
77
774
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
2.9e-01
1.3e+00
—
—
—
—
3.8e-01
cases:5.68%
controls:4.31%
cases:8.79%
controls:2.51%
—
—
—
—
—
—
—
—
cases:10.98%
controls:7.78%
5
37
83
822
8
22
83
856
—
—
—
—
9
63
73
747
Pneumonia, unspecified
J18.9 [45601123]
—
—
—
—
—
-1.0e+50
9.9e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
cases:7.32%
controls:2.84%
—
—
—
—
—
0
6
88
847
6
23
76
787
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
S46.0 [45544769]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.11%
—
—
—
—
—
—
0
9
82
801
acetylsalicylic acid; oral
B01AC06 [21600991]
1.3e+00
—
—
—
—
—
—
cases:6.82%
controls:1.86%
—
—
—
—
—
—
—
—
—
—
—
—
6
16
82
843
—
—
—
—
—
—
Cathetrisation of vein
TPH04 [2001309597]
1.5e+00
—
—
—
—
2.1e+00
—
cases:5.68%
controls:1.28%
—
—
—
—
—
—
—
—
cases:5.68%
controls:0.70%
—
—
5
11
83
848
—
—
—
—
5
6
83
847
—
Primary arthrosis of other joints
M19.0 [45601353]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
metoprolol; oral, parenteral
C07AB02 [21601684]
6.6e-01
—
—
—
—
—
—
cases:5.68%
controls:3.03%
—
—
—
—
—
—
—
—
—
—
—
—
5
26
83
833
—
—
—
—
—
—
telmisartan; oral
C09CA07 [21601830]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
Laparoscopic cholecystectomy
JKA21 [2001305294]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Other and unspecified skin changes
R23.8 [45573020]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.48%
—
—
—
—
—
—
0
12
82
798
Malaise and fatigue
R53 [45553741]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
pH of Blood
11558-4 [3010421]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Hypospadias, unspecified
Q54.9 [45548912]
—
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
—
—
—
—
—
cases:30.77%
controls:0.00%
cases:6.59%
controls:0.00%
cases:13.64%
controls:0.00%
cases:8.54%
controls:0.00%
—
—
—
28
0
63
878
6
0
85
878
12
0
76
853
7
0
75
810
apixaban; oral
B01AF02 [43534762]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
Senile incipient cataract
H25.0 [45576699]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
loperamide oxide; oral
A07DA05 [21600648]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
Blasts/Leukocytes in Blood
26446-5 [3025159]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
0
5
88
854
0
5
91
873
—
—
—
—
0
7
82
803
Memory disturbance
P20 [2002000816]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
Laboratory test
15220000 [4034850]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.59%
—
—
—
—
—
—
—
0
5
88
848
—
Atrial fibrillation/flutter
K78 [2002000605]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
—
—
—
—
—
—
0
7
82
803
ABO and Rh group [Type] in Blood
882-1 [3003694]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.37%
—
—
—
—
—
—
—
—
—
—
—
0
12
91
866
—
—
—
—
—
Headache
R51.80 [2000503603]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
folic acid
V04CX02 [715877]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Adjustment and grinding of removable appliance
SJB60 [2001310425]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
Division and ligature of inguinal hernia sac
JAB00 [2001304388]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
0
5
88
854
0
5
91
873
—
—
—
—
—
Dental X-ray, bite-wing X-ray on one side of the mouth
EB1SA [2001301918]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.94%
—
—
—
—
—
—
—
—
—
—
—
0
17
91
861
—
—
—
—
—
Vascular Surgery
77 [38004496]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.91%
—
—
—
—
—
—
—
—
—
—
—
0
8
91
870
—
—
—
—
—
ciclesonide; inhalant
R03BA08 [21603291]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
0
8
82
802
Opening and preparing the root canals, extremely complicated And time consuming
SGA05 [2001310383]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Memory test
SPAT1053 [2001700154]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
0
9
88
850
—
—
—
—
—
0
8
82
802
salbutamol; oral, parenteral
R03CC02 [21603312]
1.1e+00
-1.0e+50
—
—
—
—
7.5e-01
cases:12.50%
controls:4.66%
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
—
cases:6.10%
controls:2.96%
11
40
77
819
0
9
91
869
—
—
—
—
5
24
77
786
Dermatitis, unspecified
L30.9 [45572271]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.05%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.98%
0
9
88
850
0
5
91
873
—
—
—
—
0
16
82
794
Other medical or dental certificate
WZA90 [2001310883]
—
-1.0e+50
—
—
—
—
1.2e+00
—
—
cases:0.00%
controls:0.91%
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.98%
—
0
8
91
870
—
—
—
—
5
16
77
794
Conjunctival surface anesthesia
WX100 [2001310764]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
ispaghula (psylla seeds); oral
A06AC01 [21600555]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
0
6
88
847
—
prednisolone
S03BA02 [21605202]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
0
7
88
852
—
—
—
—
—
0
7
82
803
Observation for other suspected cardiovascular diseases
Z03.5 [45590692]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.48%
—
—
—
—
—
—
0
12
82
798
Issue of repeat prescription
Z76.0 [45542456]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.40%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
88
847
—
—
—
—
—
—
Repair of inguinal hernia using prosthetic material
JAB30 [2001304393]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
Coeliac disease
K90.0 [45586745]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Polysomnography panel
90568-7 [1002224]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Clinical photography of mouth and teeth
SBB00 [2001310298]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.11%
—
—
—
—
—
—
0
9
82
801
Conjunctival haemorrhage
H11.3 [45600854]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
hydrocortisone and antiinfectives
S01CA03 [21603654]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
0
11
82
799
Exposure to unspecified factor
X59 [45756412]
1.3e+00
—
—
—
—
—
1.5e+00
cases:6.82%
controls:1.86%
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.48%
6
16
82
843
—
—
—
—
—
5
12
77
798
Hyperplasia of prostate
N40 [45563015]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:5.49%
controls:0.00%
—
—
—
—
—
—
—
—
—
5
0
86
878
—
—
—
Back symptom/complaint
L02 [2002000627]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Eye discharge
F03 [2002000401]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
—
—
—
—
—
—
0
7
82
803
Sequelae of cerebral infarction
I69.3 [45533476]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
insulin lispro; parenteral
A10AD04 [21600732]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:3.53%
—
—
—
—
cases:0.00%
controls:1.37%
cases:0.00%
controls:4.22%
cases:0.00%
controls:6.67%
—
0
31
91
847
—
—
0
12
91
866
0
36
88
817
0
54
82
756
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.98%
—
—
—
—
—
—
0
16
82
794
Open wound of scalp
S01.0 [45592468]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Other healthcare associate professional
Z3229 [2001311561]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Cardiodefibrillation
TFP20 [2001303224]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
0
8
82
802
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
-2.0e-01
-5.9e-02
—
—
—
—
4.6e-02
cases:7.95%
controls:9.55%
cases:5.49%
controls:5.81%
—
—
—
—
—
—
—
—
cases:14.63%
controls:14.07%
7
82
81
777
5
51
86
827
—
—
—
—
12
114
70
696
Monitoring of emergency patient
SPAT1104 [2001700205]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.59%
—
—
0
7
88
852
—
—
—
—
0
5
88
848
—
calcium (different salts in combination); oral
A12AA20 [21600872]
—
—
—
—
—
—
6.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:3.21%
—
—
—
—
—
—
5
26
77
784
Fever, unspecified
R50.9 [45582716]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
0
5
91
873
—
—
—
0
6
88
847
—
Extensive health check-up at 18 months of age
SPAT1382 [2001700482]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
0
6
88
847
—
prednisolone; oral, parenteral
H02AB06 [21602734]
-1.3e-01
—
—
—
—
-1.0e+50
-5.5e-02
cases:5.68%
controls:6.40%
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.23%
cases:6.10%
controls:6.42%
5
55
83
804
—
—
—
—
0
19
88
834
5
52
77
758
Fracture of tooth, open
S02.51 [45755762]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
ezetimibe; oral
C10AX09 [21601896]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
0
6
91
872
—
—
Eosinophils [#/volume] in Blood
26449-9 [3013115]
—
—
-1.0e+50
—
—
—
6.6e-01
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
cases:12.20%
controls:6.67%
—
—
0
6
91
872
—
—
—
10
54
72
756
Student oral health check consistent with decree to assess need for oral health guidance and services
WYA50 [2001310877]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
—
—
—
—
—
—
0
7
82
803
insulin lispro; parenteral
A10AC04 [21600726]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:3.64%
—
—
—
—
cases:0.00%
controls:1.59%
cases:0.00%
controls:4.22%
cases:0.00%
controls:6.67%
—
0
32
91
846
—
—
0
14
91
864
0
36
88
817
0
54
82
756
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.1e-01
1.2e-01
1.3e+00
—
—
6.3e-02
6.3e-01
cases:12.50%
controls:10.36%
cases:8.79%
controls:7.86%
cases:6.59%
controls:1.94%
—
—
—
—
cases:7.95%
controls:7.50%
cases:23.17%
controls:13.83%
11
89
77
770
8
69
83
809
6
17
85
861
—
—
7
64
81
789
19
112
63
698
Tension-type headache
G44.2 [45581495]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.28%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
88
848
—
—
—
—
—
—
pH of Venous blood
2746-6 [3012544]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.48%
—
—
—
—
—
—
5
12
77
798
dexbrompheniramine, combinations
R06AB56 [21603469]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
enalapril; oral, parenteral
C09AA02 [21601786]
1.2e+00
7.6e-01
—
—
—
6.5e-01
9.3e-01
cases:11.36%
controls:3.84%
cases:6.59%
controls:3.19%
—
—
—
—
—
—
cases:5.68%
controls:3.05%
cases:9.76%
controls:4.07%
10
33
78
826
6
28
85
850
—
—
—
5
26
83
827
8
33
74
777
chlorhexidine
D09AA12 [21602275]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.21%
—
—
—
—
—
—
0
26
82
784
valsartan, amlodipine and hydrochlorothiazide
C09DX01 [21601846]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
diltiazem; oral
C08DB01 [21601771]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.94%
cases:0.00%
controls:0.74%
—
—
—
—
—
0
8
88
845
0
6
82
804
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Localized oedema
R60.0 [45597193]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.23%
0
5
88
854
—
—
—
—
—
0
10
82
800
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
—
—
—
—
—
—
0
7
82
803
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-5.9e-02
1.5e-01
—
—
1.5e+00
3.1e-01
5.7e-01
cases:12.50%
controls:13.15%
cases:9.89%
controls:8.66%
—
—
—
—
cases:6.59%
controls:1.59%
cases:9.09%
controls:6.80%
cases:29.27%
controls:18.89%
11
113
77
746
9
76
82
802
—
—
6
14
85
864
8
58
80
795
24
153
58
657
risperidone; oral, parenteral
N05AX08 [21604559]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
0
6
88
847
—
diclofenac; ointment
M02AA15 [21604051]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
—
0
6
91
872
—
—
—
—
0
7
82
803
insulin detemir; parenteral
A10AE05 [21600740]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:2.10%
cases:0.00%
controls:1.48%
—
—
—
—
—
—
cases:0.00%
controls:1.52%
cases:0.00%
controls:1.60%
0
18
88
841
0
13
91
865
—
—
—
0
13
88
840
0
13
82
797
Ophthalmology
18 [38004463]
5.8e-02
-1.4e-01
—
—
-1.0e+50
—
-3.7e-01
cases:12.50%
controls:11.87%
cases:5.49%
controls:6.26%
—
—
—
—
cases:0.00%
controls:1.25%
—
—
cases:12.20%
controls:16.79%
11
102
77
757
5
55
86
823
—
—
0
11
91
867
—
10
136
72
674
Orthodontic treatment/control appointment, short
SJX10 [2001310452]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
beclometasone; nasal
R01AD01 [21605043]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.23%
—
—
—
—
—
—
0
10
82
800
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:1.98%
cases:0.00%
controls:0.91%
—
—
—
—
—
—
cases:0.00%
controls:1.06%
cases:0.00%
controls:1.48%
0
17
88
842
0
8
91
870
—
—
—
0
9
88
844
0
12
82
798
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
—
—
—
—
—
—
5.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:9.76%
controls:5.80%
—
—
—
—
—
—
8
47
74
763
Excision of hydrocele of testis
KFD20 [2001306210]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
chlorphenamine, combinations
R06AB54 [21603468]
8.8e-01
-1.0e+50
—
—
—
—
—
cases:5.68%
controls:2.44%
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
5
21
83
838
0
6
91
872
—
—
—
—
—
Carpal tunnel syndrome
G56.0 [45566891]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
—
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
—
—
-1.0e+50
—
—
—
1.4e+00
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
cases:9.76%
controls:2.47%
—
—
0
6
91
872
—
—
—
8
20
74
790
prednisone; oral
H02AB07 [21602735]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
88
851
—
—
—
—
—
—
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
-2.8e-01
—
—
—
—
4.2e-01
1.1e-01
cases:11.36%
controls:14.55%
—
—
—
—
—
—
—
—
cases:6.82%
controls:4.57%
cases:12.20%
controls:11.11%
10
125
78
734
—
—
—
—
6
39
82
814
10
90
72
720
Emergency procedure
ZXD00 [2001311385]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
—
Health maint/preventive medicine
A98 [2002000231]
-1.5e-01
-1.3e-01
—
—
—
-3.7e-02
1.7e-01
cases:17.05%
controls:19.21%
cases:14.29%
controls:15.95%
—
—
—
—
—
—
cases:15.91%
controls:16.41%
cases:29.27%
controls:25.93%
15
165
73
694
13
140
78
738
—
—
—
14
140
74
713
24
210
58
600
Limited function/disability NOS
A28 [2002000162]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
—
—
—
—
—
0
7
91
871
—
—
—
—
—
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
—
—
-1.0e+50
—
—
—
9.2e-01
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
cases:10.98%
controls:4.69%
—
—
0
5
91
873
—
—
—
9
38
73
772
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.11%
—
0
6
91
872
—
—
—
—
5
9
77
801
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
hydrocortisone butyrate
D07AB02 [21602106]
-2.6e-02
—
—
—
—
—
—
cases:6.82%
controls:6.98%
—
—
—
—
—
—
—
—
—
—
—
—
6
60
82
799
—
—
—
—
—
—
Rheumatology
66 [38004491]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.40%
cases:0.00%
controls:0.80%
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
0
12
88
847
0
7
91
871
—
—
—
0
6
88
847
—
Medication, disinfection of root canals
SGC00 [2001310392]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:0.86%
0
6
88
853
—
—
—
—
—
5
7
77
803
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.70%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
0
6
88
853
0
5
91
873
—
—
—
—
—
Upper gastrointestinal surgery
106 [44777669]
3.8e-01
—
—
—
—
9.7e-01
5.3e-01
cases:6.82%
controls:4.77%
—
—
—
—
—
—
—
—
cases:6.82%
controls:2.70%
cases:10.98%
controls:6.79%
6
41
82
818
—
—
—
—
6
23
82
830
9
55
73
755
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
—
—
-1.0e+50
—
—
—
7.3e-01
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
cases:12.20%
controls:6.30%
—
—
0
6
91
872
—
—
—
10
51
72
759
Endoscopic polypectomy in colon
JFA15 [2001304850]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
lansoprazole; oral
A02BC03 [21600098]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
—
0
9
91
869
—
—
—
—
—
PEF monitoring instruction
SPAT1058 [2001700159]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
—
—
—
—
—
—
0
7
82
803
Other complicated root filling
SGB30 [2001310390]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
88
850
—
—
—
—
—
—
General anesthesia, balanced
WX408 [2001310808]
1.4e+00
—
—
—
—
1.8e+00
9.9e-01
cases:9.09%
controls:2.33%
—
—
—
—
—
—
—
—
cases:5.68%
controls:0.94%
cases:6.10%
controls:2.35%
8
20
80
839
—
—
—
—
5
8
83
845
5
19
77
791
Plastic And Reconstructive Surgery
24 [38004467]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
amoxicillin; oral, parenteral
J01CA04 [21602823]
2.0e-01
4.6e-01
—
—
—
5.0e-01
5.7e-01
cases:32.95%
controls:28.64%
cases:13.19%
controls:8.77%
—
—
—
—
—
—
cases:14.77%
controls:9.50%
cases:34.15%
controls:22.72%
29
246
59
613
12
77
79
801
—
—
—
13
81
75
772
28
184
54
626
celecoxib; oral
M01AH01 [21603992]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.70%
cases:0.00%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
0
6
88
853
0
9
91
869
—
—
—
—
—
azithromycin; oral, parenteral
J01FA10 [21602978]
2.5e-01
1.1e+00
—
—
—
7.0e-01
3.2e-01
cases:17.05%
controls:13.74%
cases:10.99%
controls:4.10%
—
—
—
—
—
—
cases:6.82%
controls:3.52%
cases:14.63%
controls:11.11%
15
118
73
741
10
36
81
842
—
—
—
6
30
82
823
12
90
70
720
Differential panel, method unspecified - Blood
69738-3 [42870588]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:10.98%
controls:4.32%
—
—
—
—
—
—
9
35
73
775
Periodontal treatment by dental hygienist, extensive
SDE03 [2001310351]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
—
Lumbago with sciatica
M54.4 [45553205]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
—
insulin lispro; parenteral
A10AB04 [21600718]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:3.64%
—
—
—
—
cases:0.00%
controls:1.59%
cases:0.00%
controls:4.22%
cases:0.00%
controls:6.67%
—
0
32
91
846
—
—
0
14
91
864
0
36
88
817
0
54
82
756
Enzyme measurement
122444009 [4046263]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
Hand/finger symptom/complaint
L12 [2002000636]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.16%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
88
849
—
—
—
—
—
—
Opiates [Presence] in Urine
3879-4 [3027008]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Urethral stricture, unspecified
N35.9 [45543870]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.54%
controls:0.00%
—
—
—
—
—
—
7
0
75
810
Other specified special examinations
Z01.8 [45581003]
1.6e+00
—
—
—
—
-1.0e+50
—
cases:5.68%
controls:1.16%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.17%
—
—
5
10
83
849
—
—
—
—
0
10
88
843
—
Unspecified fall
W19 [45756257]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
tizanidine; oral
M03BX02 [21604116]
-2.6e-01
—
—
—
—
—
—
cases:5.68%
controls:7.22%
—
—
—
—
—
—
—
—
—
—
—
—
5
62
83
797
—
—
—
—
—
—
tamsulosin and dutasteride
G04CA52 [21602673]
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
cases:0.00%
controls:1.99%
—
—
—
—
—
—
0
6
91
872
0
17
88
836
—
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.23%
—
—
—
—
—
—
5
10
77
800
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Scheduled procedure
ZXD10 [2001311387]
6.7e-01
—
—
—
—
1.6e+00
1.2e+00
cases:6.82%
controls:3.61%
—
—
—
—
—
—
—
—
cases:7.95%
controls:1.76%
cases:12.20%
controls:3.83%
6
31
82
828
—
—
—
—
7
15
81
838
10
31
72
779
Hypospadias, penile
Q54.1 [45558414]
—
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
—
—
—
—
—
cases:12.09%
controls:0.00%
cases:5.49%
controls:0.00%
cases:6.82%
controls:0.00%
cases:6.10%
controls:0.00%
—
—
—
11
0
80
878
5
0
86
878
6
0
82
853
5
0
77
810
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
7.8e-01
8.7e-01
—
—
—
1.3e+00
7.9e-01
cases:13.64%
controls:6.75%
cases:8.79%
controls:3.87%
—
—
—
—
—
—
cases:6.82%
controls:1.99%
cases:17.07%
controls:8.52%
12
58
76
801
8
34
83
844
—
—
—
6
17
82
836
14
69
68
741
Localized swelling, mass and lump, unspecified
R22.9 [45577788]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
0
8
82
802
Mucopurulent conjunctivitis
H10.0 [45596007]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Ear microscopy
UDC00 [2001301558]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
88
851
—
—
—
—
—
—
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
—
1.9e+00
—
—
—
—
8.0e-01
—
—
cases:6.59%
controls:1.03%
—
—
—
—
—
—
—
—
cases:6.10%
controls:2.84%
—
6
9
85
869
—
—
—
—
5
23
77
787
Fracture of both the crown and the root
S02.54 [2000503621]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Periodontitis complex
K05.30 [2000502728]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
0
8
82
802
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.40%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
88
847
—
—
—
—
—
—
dextromethorphan, combinations; oral
N07XX59 [43534835]
9.8e-01
-1.0e+50
—
—
—
—
—
cases:5.68%
controls:2.21%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
5
19
83
840
0
5
91
873
—
—
—
—
—
Amphetamines [Presence] in Urine
3349-8 [3027944]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
2.9e-01
-2.0e-01
-1.0e+50
—
—
1.8e-01
3.1e-01
cases:14.77%
controls:11.53%
cases:6.59%
controls:7.97%
cases:0.00%
controls:1.48%
—
—
—
—
cases:9.09%
controls:7.74%
cases:21.95%
controls:17.04%
13
99
75
760
6
70
85
808
0
13
91
865
—
—
8
66
80
787
18
138
64
672
Supine thorax X-ray examination
GD1QA [2001303648]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
0
6
88
847
—
econazole
D01AC03 [21601922]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Phakoemulsification with implantation of artificial lens in posterior chamber
CJE20 [2001301342]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.82%
cases:0.00%
controls:2.35%
—
—
—
—
—
0
7
88
846
0
19
82
791
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
—
4.6e-01
—
—
—
1.1e+00
1.2e+00
—
—
cases:5.49%
controls:3.53%
—
—
—
—
—
—
cases:5.68%
controls:1.88%
cases:13.41%
controls:4.57%
—
5
31
86
847
—
—
—
5
16
83
837
11
37
71
773
Acute lymphoblastic leukaemia [ALL]
C91.0 [45537873]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.70%
cases:0.00%
controls:1.03%
—
—
—
—
cases:0.00%
controls:0.57%
cases:0.00%
controls:0.82%
cases:0.00%
controls:0.99%
0
6
88
853
0
9
91
869
—
—
0
5
91
873
0
7
88
846
0
8
82
802
No disease
A97 [2002000230]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
—
Feeling ill
A05 [2002000146]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Neutrophils [#/volume] in Blood
26499-4 [3017732]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.60%
0
8
88
851
—
—
—
—
—
0
13
82
797
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.6e-01
—
—
—
—
—
1.2e-01
cases:5.68%
controls:4.89%
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:6.54%
5
42
83
817
—
—
—
—
—
6
53
76
757
Internal hemorrhoids without complication
I84.2 [45596267]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
candesartan; oral
C09CA06 [21601829]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.91%
—
—
—
—
—
—
—
—
—
—
0
8
91
870
—
—
—
—
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Prostate symptom/complaint
Y06 [2002001385]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Diabetes, insulin-treated
103 [2001600103]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.91%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.73%
—
0
8
91
870
—
—
—
—
0
14
82
796
Syncope and collapse
R55 [45568141]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Internal Medicine
11 [38004456]
-1.0e-02
5.5e-02
—
—
—
—
-1.8e-01
cases:14.77%
controls:14.90%
cases:6.59%
controls:6.26%
—
—
—
—
—
—
—
—
cases:14.63%
controls:17.04%
13
128
75
731
6
55
85
823
—
—
—
—
12
138
70
672
Other complicated additional procedure necessary for restorative treatment
SFC92 [2001310370]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
88
850
—
—
—
—
—
—
General health counselling
SPAT1312 [2001700413]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.14%
—
—
—
—
—
—
—
—
—
—
—
0
10
91
868
—
—
—
—
—
Ingrowing nail
L60.0 [45548199]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
Fat metabolism disorder associated with chronic coronary artery disease
213 [2001600209]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
Cough
R05 [45606792]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.17%
—
—
—
—
—
—
—
0
10
88
843
—
Application of soft bandage
SPAT1211 [2001700312]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
terbinafine; oral
D01BA02 [21601967]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
cases:0.00%
controls:0.94%
—
—
—
0
7
91
871
—
—
—
0
8
88
845
—
chlorhexidine
S02AA09 [21605155]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.21%
—
—
—
—
—
—
0
26
82
784
alprazolam; oral
N05BA12 [21604577]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
88
854
—
—
—
—
—
—
tiotropium bromide; inhalant
R03BB04 [21603296]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
0
6
91
872
—
—
—
0
6
88
847
—
dextromethorphan; oral
R05DA09 [21603404]
9.3e-01
-1.0e+50
—
—
—
—
—
cases:5.68%
controls:2.33%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
5
20
83
839
0
5
91
873
—
—
—
—
—
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.86%
—
—
—
—
—
—
0
7
82
803
Besnier prurigo
L20.0 [45562534]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
0
11
82
799
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
0
6
91
872
—
—
—
—
—
Congenital anomalies of genital organs, Hypospadias and epispadias[HYPOSPADIA]
7526B [2000406478]
1.0e+50
—
—
—
—
—
—
cases:7.95%
controls:0.00%
—
—
—
—
—
—
—
—
—
—
—
—
7
0
81
859
—
—
—
—
—
—
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:1.85%
—
—
—
—
—
—
6
15
76
795
Counselling related to known health issue
SPAT1310 [2001700411]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:2.21%
cases:0.00%
controls:1.59%
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
0
19
88
840
0
14
91
864
—
—
—
0
7
88
846
—
Chest pain, unspecified
R07.4 [45558450]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.59%
—
—
—
—
—
—
—
0
5
88
848
—
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
0
5
88
854
—
—
—
—
—
0
5
82
805
Small restoration
SFA00 [2001310357]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
9.6e-02
3.7e-01
1.1e+00
—
1.0e+00
3.1e-01
3.6e-01
cases:15.91%
controls:14.67%
cases:16.48%
controls:11.96%
cases:8.79%
controls:2.96%
—
—
cases:5.49%
controls:2.05%
cases:14.77%
controls:11.25%
cases:29.27%
controls:22.35%
14
126
74
733
15
105
76
773
8
26
83
852
—
5
18
86
860
13
96
75
757
24
181
58
629
hydrocortisone
D07XA01 [21602180]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:3.21%
—
—
—
—
—
—
0
26
82
784
Right side
ZXA00 [2001311346]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.84%
—
—
—
—
—
—
0
23
82
787
podophyllotoxin
D06BB04 [21602086]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
0
8
82
802
Rectal ultrasound examination of prostate
KE1BE [2001306106]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.59%
—
—
—
—
—
—
—
0
5
88
848
—
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.9e-01
4.2e-01
9.1e-01
—
1.6e+00
5.2e-01
6.2e-01
cases:12.50%
controls:9.66%
cases:12.09%
controls:8.31%
cases:5.49%
controls:2.28%
—
—
cases:5.49%
controls:1.14%
cases:12.50%
controls:7.85%
cases:26.83%
controls:16.54%
11
83
77
776
11
73
80
805
5
20
86
858
—
5
10
86
868
11
67
77
786
22
134
60
676
Pure hypercholesterolaemia
E78.01 [2000501514]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
18
88
841
—
—
—
—
—
—
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.75%
—
—
—
—
—
—
—
—
—
—
—
—
0
15
88
844
—
—
—
—
—
—
Two-surface restoration
SFA20 [2001310359]
—
4.4e-01
—
—
-1.0e+50
7.3e-01
2.4e-01
—
—
cases:6.59%
controls:4.33%
—
—
—
—
cases:0.00%
controls:0.68%
cases:6.82%
controls:3.40%
cases:13.41%
controls:10.86%
—
6
38
85
840
—
—
0
6
91
872
6
29
82
824
11
88
71
722
Extended examination of mouth
SAA03 [2001310276]
—
—
—
—
—
—
1.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:6.42%
—
—
—
—
—
—
6
52
76
758
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
-1.0e+50
—
—
—
—
—
1.3e+00
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.73%
0
7
88
852
—
—
—
—
—
5
14
77
796
Pain, unspecified
R52.9 [45544151]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
0
6
88
853
—
—
—
—
—
0
5
82
805
Pediatric Gastroenterology
OMOP4822029 [45756810]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
tamsulosin; oral
G04CA02 [21602669]
—
8.4e-01
—
—
—
—
4.4e-01
—
—
cases:6.59%
controls:2.96%
—
—
—
—
—
—
—
—
cases:8.54%
controls:5.68%
—
6
26
85
852
—
—
—
—
7
46
75
764
Hydrocele, unspecified
N43.3 [45572714]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
Photography of fundus of eye
XCK10 [2001301381]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.82%
cases:0.00%
controls:2.10%
—
—
—
—
—
0
7
88
846
0
17
82
793
Skin symptom/complaint other
S29 [2002000993]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.16%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
0
10
88
849
0
5
91
873
—
—
—
0
6
88
847
—
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
—
—
—
—
—
—
3.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:4.32%
—
—
—
—
—
—
5
35
77
775
enoxaparin; parenteral
B01AB05 [21600976]
1.3e+00
—
—
—
—
—
1.5e+00
cases:5.68%
controls:1.63%
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.36%
5
14
83
845
—
—
—
—
—
5
11
77
799
Fracture of upper end of humerus
S42.2 [45544677]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
promethazine, combinations
R06AD52 [21603489]
9.8e-01
-1.0e+50
—
—
—
—
—
cases:5.68%
controls:2.21%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
5
19
83
840
0
5
91
873
—
—
—
—
—
ranitidine; oral, parenteral
A02BA02 [21600083]
1.4e+00
—
—
—
—
—
—
cases:5.68%
controls:1.51%
—
—
—
—
—
—
—
—
—
—
—
—
5
13
83
846
—
—
—
—
—
—
Atrial fibrillation and atrial flutter, unspecified
I48.9 [45755409]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
0
6
82
804
naproxcinod
M01AE18 [40254094]
-2.7e-01
—
-1.0e+50
—
—
—
6.1e-02
cases:5.68%
controls:7.33%
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
cases:7.32%
controls:6.91%
5
63
83
796
—
0
5
91
873
—
—
—
6
56
76
754
Gas panel - Arterial blood
24336-0 [3019060]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
88
853
—
—
—
—
—
—
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.2e-01
1.2e+00
—
—
—
—
4.5e-01
cases:5.68%
controls:4.19%
cases:7.69%
controls:2.51%
—
—
—
—
—
—
—
—
cases:10.98%
controls:7.28%
5
36
83
823
7
22
84
856
—
—
—
—
9
59
73
751
oxycodone and naloxone; oral
N02AA55 [21604265]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
0
8
82
802
saccharomyces boulardii; oral
A07FA02 [21600670]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
88
851
—
—
—
—
—
—
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
5
82
805
fluticasone; inhalant
R03BA05 [21603288]
8.9e-01
—
—
—
—
1.1e+00
7.5e-01
cases:6.82%
controls:2.91%
—
—
—
—
—
—
—
—
cases:5.68%
controls:1.88%
cases:6.10%
controls:2.96%
6
25
82
834
—
—
—
—
5
16
83
837
5
24
77
786
Extraction of tooth
EBA00 [2001301923]
—
—
—
—
—
—
4.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:4.07%
—
—
—
—
—
—
5
33
77
777
Essential (primary) hypertension
I10 [45591453]
7.9e-01
4.6e-01
—
—
—
8.9e-01
5.8e-01
cases:17.05%
controls:8.50%
cases:9.89%
controls:6.49%
—
—
—
—
—
—
cases:10.23%
controls:4.45%
cases:18.29%
controls:11.11%
15
73
73
786
9
57
82
821
—
—
—
9
38
79
815
15
90
67
720
Anaemia, unspecified
D64.9 [45600610]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
0
8
82
802
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
0
5
88
854
0
5
91
873
—
—
—
—
—
Tooth X-ray additional picture
EB1CA [2001301909]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
0
8
88
851
—
—
—
—
—
0
6
82
804
spironolactone; oral
C03DA01 [21601534]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.11%
—
—
—
—
—
—
0
9
82
801
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.40%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.99%
0
12
88
847
—
—
—
—
—
0
8
82
802
Operative extraction of tooth
EBA10 [2001301925]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
88
851
—
—
—
—
—
—
Preventive oral health care, short
SCA01 [2001310302]
—
—
—
—
—
—
3.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:5.43%
—
—
—
—
—
—
6
44
76
766
Spinal stenosis
M48.0 [45557888]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.28%
cases:0.00%
controls:0.80%
—
—
—
—
—
—
—
—
—
—
0
11
88
848
0
7
91
871
—
—
—
—
—
mometasone; nasal
R01AD09 [21605051]
6.3e-02
—
-1.0e+50
—
—
9.2e-01
5.3e-01
cases:5.68%
controls:5.36%
—
—
cases:0.00%
controls:0.68%
—
—
—
—
cases:5.68%
controls:2.34%
cases:10.98%
controls:6.79%
5
46
83
813
—
0
6
91
872
—
—
5
20
83
833
9
55
73
755
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2500B [2000402295]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.44%
—
—
—
—
—
—
—
—
—
—
—
—
0
21
88
838
—
—
—
—
—
—
phenylephrine, combinations
R01BA53 [21603214]
8.8e-01
-1.0e+50
—
—
—
—
—
cases:5.68%
controls:2.44%
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
5
21
83
838
0
6
91
872
—
—
—
—
—
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
0
5
91
873
—
—
—
—
—
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
88
850
—
—
—
—
—
—
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
K40.9 [45543307]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.60%
—
0
6
91
872
—
—
—
—
0
13
82
797
Periodontitis pronounced
K05.31 [2000502729]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
88
851
—
—
—
—
—
—
Nonallergic asthma
J45.1 [45557625]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.10%
controls:1.11%
—
—
—
—
—
—
5
9
77
801
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
cases:0.00%
controls:0.59%
cases:0.00%
controls:1.36%
—
0
7
91
871
—
—
—
0
5
88
848
0
11
82
799
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:1.25%
—
—
—
—
—
—
cases:0.00%
controls:0.59%
—
—
—
0
11
91
867
—
—
—
0
5
88
848
—
Obesity due to excess calories
E66.01 [2000501501]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.59%
—
—
—
—
—
—
—
0
5
88
848
—
Audiometric test
21727005 [4071702]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.94%
—
—
—
—
—
—
—
0
8
88
845
—
Albumin [Mass/volume] in Urine
1754-1 [3012516]
—
—
—
—
—
—
2.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.32%
controls:5.68%
—
—
—
—
—
—
6
46
76
764
levodopa and decarboxylase inhibitor; oral
N04BA02 [21604465]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.70%
cases:0.00%
controls:0.57%
—
—
—
—
—
—
cases:0.00%
controls:0.59%
—
—
0
6
88
853
0
5
91
873
—
—
—
0
5
88
848
—
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
8.8e-01
—
—
—
—
—
—
cases:5.68%
controls:2.44%
—
—
—
—
—
—
—
—
—
—
—
—
5
21
83
838
—
—
—
—
—
—
Teeth/gum disease
D82 [2002000380]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.25%
—
—
—
—
—
—
—
—
—
—
—
0
11
91
867
—
—
—
—
—
Necrosis of pulp
K04.1 [45572186]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.81%
cases:0.00%
controls:0.80%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
0
7
88
852
0
7
91
871
—
—
—
—
0
5
82
805
loperamide; oral
A07DA03 [21600646]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
88
852
—
—
—
—
—
—
Otitis media, unspecified
H66.9 [45547965]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
0
6
91
872
—
—
—
—
—
Chronic hypertension
205 [2001600203]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
0
6
91
872
—
—
—
—
—
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.1e+00
—
—
—
—
—
2.0e-01
cases:10.23%
controls:3.49%
—
—
—
—
—
—
—
—
—
—
cases:9.76%
controls:8.15%
9
30
79
829
—
—
—
—
—
8
66
74
744
fluticasone; nasal
R01AD08 [21605050]
—
—
—
—
-1.0e+50
—
1.2e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
cases:6.10%
controls:5.43%
—
—
—
—
0
5
91
873
—
5
44
77
766
Pain in limb
M79.6 [45587063]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.17%
—
—
—
—
—
—
—
0
10
88
843
—
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 [2002330110]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
18
88
841
—
—
—
—
—
—
Infiltration anesthesia
WX110 [2001310767]
-2.4e-01
7.6e-01
—
—
—
5.1e-01
4.6e-01
cases:7.95%
controls:9.90%
cases:9.89%
controls:4.90%
—
—
—
—
—
—
cases:6.82%
controls:4.22%
cases:17.07%
controls:11.48%
7
85
81
774
9
43
82
835
—
—
—
6
36
82
817
14
93
68
717
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
88
851
—
—
—
—
—
—
Other function in accordance with SHToL (Finnish classification of nursing interventions)
SPAT1292 [2001700393]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.23%
—
—
—
—
—
—
0
10
82
800

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
149
2.67
5.39
5.1
2.4
—
—
—
0
0
7
9
8.10
3.60
1.1
1.1
—
—
—
0
0
17
73
2.50
2.77
7.1
3.2
—
—
—
0
0
59
411
1.73
2.58
3.8
3.1
6.08
6.20
ph
0.47
31
225
7
16
4.54
2.50
9.7
4.9
7.77
10.06
pmol/l
—
7
16
10
32
3.28
2.49
8.1
3.3
7.41
7.39
ph
—
10
32
38
242
1.77
2.23
5.0
5.6
—
—
—
0
0
46
310
1.71
2.22
2.0
1.9
91.63
94.26
pmol/l
0.16
29
167
41
268
1.74
2.20
4.9
2.5
0.00
0.00
estimate
-0.00
18
83
50
355
1.62
1.95
6.0
3.7
90.16
30.34
e6/l
0.54
44
267
50
366
1.56
1.69
5.2
2.9
0.00
0.00
estimate
-0.00
16
93
45
322
1.57
1.67
6.3
3.5
0.27
0.22
e6/l
0.17
39
234
65
505
1.52
1.67
5.2
3.4
0.00
0.00
estimate
-0.00
20
103
65
509
1.50
1.59
5.2
3.4
0.00
0.00
estimate
-0.00
19
91
5
15
3.41
1.53
5.4
6.1
1.80
3.44
ug/l
—
5
15
5
16
3.20
1.45
3.2
4.2
3.65
3.67
e9/l
—
5
16
53
405
1.48
1.43
7.0
4.6
49.58
46.91
e6/l
0.03
46
279
63
501
1.45
1.39
5.3
3.3
0.00
0.00
estimate
-0.00
19
107
6
23
2.68
1.38
8.7
3.0
5.13
4.80
kpa
—
6
23
6
23
2.68
1.38
8.7
3.0
9.12
8.50
kpa
—
6
23
36
257
1.53
1.33
5.4
4.0
7.39
7.39
ph
0.11
26
181
36
257
1.53
1.33
6.0
3.3
0.00
0.01
estimate
0.49
20
94
23
147
1.67
1.33
1.8
1.8
—
—
—
0
0
24
161
1.59
1.16
12.2
12.7
105.83
104.66
mmol/l
0.75
24
161
5
20
2.55
1.16
1.4
1.1
281.40
201.47
pmol/l
—
5
20
11
59
1.93
1.10
1.1
1.2
—
—
—
0
0
24
165
1.54
1.05
2.2
2.2
—
—
—
0
0
63
521
1.37
1.05
11.3
11.8
1.24
1.21
mmol/l
1.70
57
477
5
22
2.32
1.04
4.6
2.3
199.80
167.97
ug/min
—
5
14
23
157
1.55
1.04
2.2
2.2
—
—
—
0
0
24
166
1.53
1.03
2.2
2.1
—
—
—
0
0
24
167
1.52
1.00
2.2
2.2
—
—
—
0
0
20
134
1.57
0.98
2.1
2.1
372.15
341.77
nmol/l
0.29
20
126
89
783
1.35
0.97
3.7
3.1
14.66
15.02
pmol/l
0.74
79
714
11
63
1.81
0.93
22.5
20.8
25.18
23.79
mmol/l
1.57
11
63
11
64
1.78
0.89
3.3
3.3
—
—
—
0
0
23
165
1.47
0.84
2.2
2.2
—
—
—
0
0
0
24
0.00
0.80
0.0
6.3
—
0.19
—
0
14
0
25
0.00
0.80
0.0
4.4
—
—
—
0
0
38
302
1.35
0.79
1.6
1.8
—
—
—
0
0
12
76
1.63
0.74
21.3
18.2
0.52
0.68
%
1.14
12
76
5
26
1.95
0.71
12.4
5.4
—
—
—
0
0
9
58
1.59
0.71
4.8
14.9
0.60
0.59
%
—
9
58
12
77
1.61
0.71
21.3
18.0
0.90
1.56
%
2.71
12
77
77
683
1.27
0.70
6.4
12.0
0.18
0.22
e9/l
1.43
67
590
103
948
1.29
0.69
4.1
3.8
2.02
2.02
mu/l
0.01
97
880
7
43
1.66
0.68
1.6
2.0
—
52.22
—
0
9
48
404
1.28
0.67
3.8
3.5
—
—
estimate
—
0
0
5
28
1.81
0.67
1.8
1.7
6.17
9.42
u/ml
—
5
21
47
396
1.28
0.64
2.3
2.1
1.39
1.42
mmol/l
0.09
38
349
26
202
1.35
0.63
7.0
8.4
0.84
0.82
mmol/l
0.37
26
197
11
72
1.57
0.61
23.2
19.2
96.64
93.75
%
1.92
11
72
80
722
1.24
0.60
7.8
14.5
3.77
3.89
e9/l
0.21
68
616
17
124
1.42
0.59
1.6
2.1
—
—
—
0
0
5
86
0.57
0.58
1.8
1.7
—
0.39
—
0
43
49
421
1.25
0.57
3.5
2.8
—
—
—
0
0
9
59
1.56
0.56
4.8
14.6
1.06
1.53
%
—
9
59
45
385
1.24
0.54
3.9
3.6
9.80
8.99
mmol/l
0.46
38
359
24
190
1.31
0.52
1.4
1.6
—
—
—
0
0
6
40
1.52
0.52
1.0
1.5
19.83
32.65
ng/l
—
6
40
13
93
1.44
0.50
1.2
1.2
—
—
—
0
0
7
45
1.58
0.49
1.3
1.7
—
—
—
0
0
25
201
1.29
0.49
5.5
3.6
1.66
0.69
e6/l
0.41
16
107
83
896
0.83
0.48
4.6
3.9
5.96
5.84
mmol/l
0.30
68
834
24
193
1.29
0.47
16.5
17.3
25.13
24.59
mmol/l
0.32
24
193
122
1167
1.28
0.46
13.7
10.9
—
—
—
0
0
22
176
1.29
0.45
16.6
13.8
—
—
—
0
0
69
627
1.19
0.44
10.5
14.6
0.00
0.00
e9/l
0.54
55
503
73
668
1.19
0.43
6.7
10.9
0.04
0.04
e9/l
0.87
65
569
8
57
1.43
0.43
2.8
4.8
7.27
7.32
ph
—
8
42
73
669
1.18
0.42
6.7
10.8
0.57
0.60
e9/l
0.45
65
568
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
13227.00
—
0
10
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
0
19
0.00
0.39
0.0
2.2
—
84.16
—
0
19
14
107
1.34
0.39
1.3
1.3
—
—
—
0
0
30
255
1.22
0.38
4.5
4.3
14.76
66.04
mg/mmol
0.43
23
195
34
294
1.20
0.37
1.4
1.4
—
—
—
0
0
15
117
1.31
0.37
1.7
1.7
—
—
—
0
0
74
688
1.15
0.33
6.7
10.8
1.91
2.16
e9/l
1.23
67
600
29
250
1.20
0.33
3.9
3.0
1.02
1.02
kg/l
0.12
19
162
29
254
1.18
0.28
3.7
3.6
130.07
76.80
mg/l
0.49
23
195
13
104
1.27
0.27
1.8
1.5
—
—
—
0
0
95
992
0.88
0.27
5.5
4.5
2.71
2.70
mmol/l
0.04
87
943
89
933
0.88
0.27
4.2
3.6
1.42
1.30
mmol/l
0.93
82
886
5
75
0.65
0.26
1.4
1.6
—
—
—
0
0
22
189
1.19
0.26
6.3
11.6
7.38
7.37
ph
1.15
15
124
9
75
1.21
0.25
4.3
2.3
5.84
7.16
ug/l
—
9
69
53
490
1.13
0.25
13.7
12.4
1.24
1.22
mmol/l
1.31
53
466
24
209
1.18
0.25
1.7
3.8
0.79
1.93
mg/l
1.58
18
166
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
70
661
1.11
0.23
3.9
3.4
—
—
—
0
0
5
42
1.20
0.21
3.6
2.6
54.00
54.69
%
—
5
42
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
7.3
—
1.18
—
0
5
0
12
0.00
0.21
0.0
1.2
—
1.76
—
0
12
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
9
115
0.77
0.20
2.2
1.8
—
—
—
0
0
120
1170
1.14
0.20
17.5
13.9
26.45
25.09
mg/l
0.15
88
879
0
14
0.00
0.20
0.0
1.0
—
173.64
—
0
14
95
983
0.90
0.19
4.9
4.1
1.28
1.29
mmol/l
0.15
86
935
6
52
1.16
0.19
3.2
3.5
—
—
—
0
0
21
185
1.16
0.19
1.8
1.8
—
—
—
0
0
7
58
1.22
0.18
1.0
1.3
—
—
—
0
0
5
70
0.70
0.17
1.0
1.1
—
—
—
0
0
42
397
1.08
0.12
6.8
11.1
1.07
1.20
inr
2.01
34
338
31
289
1.09
0.12
2.0
1.9
—
—
—
0
0
45
428
1.07
0.11
5.2
4.7
1.80
2.46
ug/l
0.35
40
387
5
43
1.17
0.10
4.6
3.5
570.40
719.16
ug/l
—
5
43
26
278
0.92
0.10
2.5
2.1
—
—
—
0
0
5
46
1.09
0.09
9.6
5.3
23.60
23.94
mmol/l
—
5
46
33
312
1.07
0.09
4.4
3.5
19.31
23.71
ng/l
0.45
21
199
6
54
1.12
0.09
2.3
3.5
—
—
—
0
0
38
398
0.94
0.08
2.8
9.4
—
—
—
0
0
6
58
1.04
0.08
1.2
1.2
—
—
—
0
0
24
256
0.93
0.08
3.7
3.2
—
—
—
0
0
51
492
1.06
0.08
6.5
11.2
—
—
—
0
0
132
1332
0.91
0.07
22.8
20.8
4.84
4.78
e12/l
0.58
126
1289
132
1332
0.91
0.07
22.9
20.9
6.54
6.75
e9/l
0.67
126
1288
28
266
1.07
0.06
5.5
5.0
—
—
—
0
0
32
307
1.05
0.05
3.6
3.5
—
—
—
0
0
132
1330
0.92
0.05
22.8
20.9
251.17
250.18
e9/l
0.06
127
1288
37
382
0.96
0.04
1.6
1.7
8.43
2.27
u/ml
—
9
87
15
160
0.93
0.04
3.1
2.1
—
—
—
0
0
16
170
0.93
0.04
5.9
7.0
—
—
—
0
0
98
991
0.97
0.03
4.9
4.2
4.44
4.42
mmol/l
0.10
90
949
35
343
1.03
0.01
2.0
1.8
1.84
2.08
g/l
0.49
21
190
14
134
1.05
0.00
1.4
1.5
—
—
—
0
0
16
156
1.03
0.00
1.4
1.3
—
—
—
0
0
12
117
1.03
0.00
2.2
1.9
—
—
—
0
0
14
143
0.98
0.00
2.6
3.1
4.74
5.85
e9/l
0.27
14
131
26
255
1.02
0.00
2.8
2.8
0.75
0.77
ug/l
0.04
16
143
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
2040.00
—
0
5
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
1262.40
—
0
5
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
75.12
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
29.28
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.6
—
0.88
—
0
5
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
6.48
—
0
6
5
55
0.91
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
4.97
—
0
6
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
0.58
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
160.83
—
0
6
0
6
0.00
-0.00
0.0
16.7
—
0.52
—
0
6
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
55
0.91
-0.00
1.8
1.4
266.20
341.57
mu/l
—
5
55
0
6
0.00
-0.00
0.0
1.5
—
4.25
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_HYPOSPADIAS – Hypospadias

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).